×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AEON – aeon biopharma, inc. class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AEON
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/3
04:10 pm
aeon
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
Low
Report
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
4/3
04:05 pm
aeon
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
Low
Report
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
3/30
04:05 pm
aeon
AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program
Low
Report
AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program
3/25
08:00 am
aeon
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
Low
Report
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
3/9
04:05 pm
aeon
AEON Biopharma Appoints John Bencich as Chief Financial Officer
Medium
Report
AEON Biopharma Appoints John Bencich as Chief Financial Officer
3/5
04:05 pm
aeon
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
Low
Report
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
1/21
04:05 pm
aeon
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
High
Report
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/3
06:22 pm
aeon
Form 3 AEON Biopharma, Inc. For: Apr 01 Filed by: Bencich John
Low
Report
Form 3 AEON Biopharma, Inc. For: Apr 01 Filed by: Bencich John
4/3
06:22 pm
aeon
Form 4 AEON Biopharma, Inc. For: Apr 02 Filed by: Bencich John
Low
Report
Form 4 AEON Biopharma, Inc. For: Apr 02 Filed by: Bencich John
3/11
08:14 pm
aeon
Form 4 AEON Biopharma, Inc. For: Feb 17 Filed by: Oh Chad
Low
Report
Form 4 AEON Biopharma, Inc. For: Feb 17 Filed by: Oh Chad
3/9
04:06 pm
aeon
Form 8-K AEON Biopharma, Inc. For: Mar 06
Medium
Report
Form 8-K AEON Biopharma, Inc. For: Mar 06
3/5
06:08 pm
aeon
Form 4 AEON Biopharma, Inc. For: Feb 17 Filed by: Wilson Alexander Blair
Low
Report
Form 4 AEON Biopharma, Inc. For: Feb 17 Filed by: Wilson Alexander Blair
3/5
06:06 pm
aeon
Form 4 AEON Biopharma, Inc. For: Feb 17 Filed by: Sy Jennifer
Low
Report
Form 4 AEON Biopharma, Inc. For: Feb 17 Filed by: Sy Jennifer
2/19
08:40 pm
aeon
Form 4 AEON Biopharma, Inc. For: Feb 17 Filed by: Bancroft Robert E.
Low
Report
Form 4 AEON Biopharma, Inc. For: Feb 17 Filed by: Bancroft Robert E.
2/18
04:06 pm
aeon
Form 424B3 AEON Biopharma, Inc.
Medium
Report
Form 424B3 AEON Biopharma, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: